Related Experiment Videos

A no-touch technique protocol to diminish cerebrospinal fluid shunt infection

W J Faillace1

  • 1Department of Neurosurgery and Pediatrics, University of Florida Health Science Center, Jacksonville 32209, USA.

Surgical Neurology
|April 1, 1995
PubMed
Abstract

Insights

A new no-touch technique protocol significantly reduced cerebrospinal fluid (CSF) shunt infections by threefold. This method offers a promising strategy to lower infection rates in patients undergoing shunt placement surgery.

Area of Science:

  • Neurosurgery
  • Infectious Disease Prevention
  • Medical Device Technology

Background:

  • Cerebrospinal fluid (CSF) shunts are susceptible to bacterial infections from skin flora, operating room environments, or other sources.
  • High incidence of shunt infection necessitates strategies to improve patient safety and outcomes.
  • A novel no-touch technique protocol was implemented to mitigate the risk of shunt infection.

Purpose of the Study:

  • To evaluate the efficacy of a no-touch technique protocol in reducing the incidence of CSF shunt infections.
  • To compare infection rates in patients who underwent shunt placement with versus without the no-touch technique.

Main Methods:

  • A before-after trial design was employed to analyze infection rates.
  • Patients were stratified based on age, hydrocephalus etiology, surgery type, and presence of contaminated wounds.
  • Statistical analysis included the Fisher exact test and calculation of confidence intervals for odds ratios.

Main Results:

  • The no-touch technique protocol demonstrated a threefold decrease in shunt infection rate, from 9.1% to 2.9% (p=0.058).
  • Infection rate per patient decreased nearly threefold, from 11.3% to 3.9% (p=0.032).
  • The protocol yielded an odds ratio of 0.305 for overall infection and 0.243 for infection per patient.

Conclusions:

  • The no-touch technique protocol is an effective method for reducing CSF shunt infections.
  • Further validation through larger, prospective, randomized, multicenter trials is recommended to confirm the protocol's efficacy.

Related Concept Videos